Press release
Orthofix Names Julie Dewey Chief Investor Relations and Communications Officer; Max Reinhardt Begins as President of Global Spine
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of
About this update from Orthofix Medical Inc.
[{"type":"text","content":" LEWISVILLE, Texas--(BUSINESS WIRE)--\nOrthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Julie Dewey as Chief Investor Relations and Communications Officer. Additionally, as previously announced, Max Reinhardt begins as President of the company’s global spine business. Dewey and Reinhardt will serve on Orthofix’s Executive Leadership Team.\n\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611316728/en/Julie Dewey, Chief Investor Relations and Communications Officer, Orthofix Medical Inc. (Photo: Business Wire)\nA seasoned investor relations and communications executive, Dewey previously held roles as a corporate officer for multiple global publicly traded medical device companies. Most recently, she served as Chief Communications and Investor Relations Officer for Treace Medical Concepts, Inc., a medical technology company focused on the surgical management of bunion and related midfoot deformities. Earlier in her career, she was the Senior Vice President and Chief Communications Officer at Wright Medical Group, a global medical device company focused on extremities and biologics that was acquired by Stryker in 2020.\n\n\n“We are excited to welcome Julie to the company,” said Orthofix President and Chief Executive Officer Massimo Calafiore. “She is deeply respected within the industry and brings with her vast knowledge of our markets, technologies, and growth strategies. Her appointment not only strengthens our executive leadership team, but it also further establishes our focus on expanding our outreach with investors and analysts as we continue to drive profitability and growth for our shareholders.”\n\n\nDewey is known for her strong focus on transformative IR program development, successfully positioning medical technology companies in the financial market, and expanding outreach and engagement with the investment community.\n\n\n“I am thrilled to join Orthofix in this new leadership role at such a transformational time in its growth trajectory,” said Dewey. “I look forward to working with Massimo and the rest of the Orthofix team to execute on the company's growth strategy and deliver a best-in-class experience for the investment community and key stakeholders.”\n\n\nAbout Julie Dewey\n\n\nJ...